Eli Lilly’s Zepbound is off to a strong start, but here’s what needs to happen to push shares higher

[ad_1]

Investors will be tuning into the company's fourth quarter earnings call on Feb. 6, eager to hear more about how the rollout of Zepbound is going.

[ad_2]

Source link